Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-10-31
2006-10-31
Zeman, Mary K. (Department: 1631)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023720, C536S024320, C424S184100, C424S189100, C424S204100, C424S228100, C435S006120, C435S069100, C435S069300, C435S235100, C435S320100, C435S948000, C530S300000, C530S350000, C530S860000, C530S826000
Reexamination Certificate
active
07129337
ABSTRACT:
The present invention relates to new genomic nucleotide sequences and amino acid sequences corresponding to the coding region of these genomes. The invention relates to new HCV types and subtypes sequences which are different from the known HCV types and subtypes sequences. More particularly, the present invention relates to new HCV type 7 sequences, new HCV type 9 sequences, new HCV type 10 and new HCV type 11 sequences. Also, the present invention relates to new HCV type 1 sequences of subtypes 1d, 1e, 1f and 1g; new HCV type 2 sequences of subtypes 2e, 2f, 2g, 2h, 2i, 2k and 2l; new HCV type 3 sequences of subtype 3g, new HCV type 4 sequences of subtypes 4k, 4l and 4m; a process for preparing them, and their use for diagnosis, prophylaxis and therapy. More particularly, the present invention provides new type-specific sequences of the Core, the E1 and the NS5 regions of new HCV types 7, 9, 10 and 11, as well as of new variants (subtypes) of HCV types 1, 2, 3 and 4. These new HCV sequences are useful to diagnose the presence of HCV type 1, and/or type 2, and/or type 3, and/or type 4, and/or type 7, and/or type 9, and/or type 10, and/or type 11 genotypes or serotypes in a biological sample. Moreover, the availability of these new type-specific sequences can increase the overall sensitivity of HCV detection and should also prove to be useful for prophylactic and therapeutic purposes.
REFERENCES:
patent: 5372928 (1994-12-01), Miyamura et al.
patent: 5514539 (1996-05-01), Bukh et al.
patent: 0 388 232 (1990-09-01), None
patent: 419182 (1991-03-01), None
patent: 0463848 (1992-01-01), None
patent: A-0 532 167 (1993-03-01), None
patent: 2239245 (1991-06-01), None
patent: 6-319563 (1994-11-01), None
patent: WO 92/19743 (1992-11-01), None
patent: 93-00365 (1993-01-01), None
patent: WO 93/06126 (1993-04-01), None
patent: WO 93/10239 (1993-05-01), None
patent: 94-25601 (1994-11-01), None
patent: WO-A-95 01442 (1995-01-01), None
Liu et al. Jan. 1992 Gene 114 (2) 245-250.
Stuyver et al. 194 Journal of General Virology 74 (6) 1093-1102, Jan. 1994.
Stuyver et al. Jan. 1994 PNAS USA 91 (21) 10134-10138.
van Doorn et al, Jan. 1994 Journal of Hepatology 21 (1) 122-129.
Qu et al. 1994 Journal of General Virology 75 (5) 1063-1070, May 1994.
Bukh. J. et al. “At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of insulates collected worldwide” Proceedings of the National Academy of Sciences of USA, vol. 90. pp. 8234-8238.
Bukh, J. et al. “Sequence analysis of the core gene of the 14 hepatitis C virus genotype”, Proceedings of the National Academy of Sciences of USA. vol. 91. pp. 8239-8424.
Driesel, G. et al. “Hepatitis C virus (HCV) genotype distribution in german isolates: studies on the sequence variabiity in the E2 and NS5 region”, Archives of Virology, vol. 139. No. 3/04. pp. 379-388.
Tokita, H. et al. “Hepatitis C virus variants from vietnam are classifiable into the seventh, eighth and ninth major genenetic groups”, Proceedings of the National Academy of Sciences of USA, vol. 91, No. 23. pp. 11022-11026.
Stuyver et al. “Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples”, Virus Research, vol. 30, No. 2-3, pp. 137-157.
Simmonds P. et al, “Mapping of serotype-specific immunodominant epitopes in the NS4 region of hepatitis C virus”, J. Clin. Micro., vol. 31. No. 6. 1993. pp. 1493-1503.
Stuyver, L. et al. “Analays of the putative E1 envelope and NS4a epitope regions of HCV type 3”, Biochem. Biophys. Res. Commun., vol. 192, No. 2, 1993. pp. 635-641.
Chayama, K. et al. “Genotypic subtyping of hepatitis C virus”, J. Gastroenterol. Hepatol., vol. 8, 1993, pp. 150-156.
Weiner et al, “Variable and hypervariable regions of HCV corresponding to the flavivrus envelope and NS1 proteins”, Virology. vol. 180. 1991 pp. 842-848.
Bukh et al. PNAS 89 4942-4946, Jun. 1992.
Wallace et al. “Methods in Enzymology”, 152:432 (1987).
Cha. T.A. et al. “At least five related but distinct genotypes of hepatitis C virus exist”, Proc. Natl. Acad. Sci. USA, vol. 89, 1992. pp. 7144-7148.
Apichartpiyakul et al., Journal of Clinical Microbiology, Sep. 1994, pp. 2276-2279, vol. 32, No. 9.
Kato et al, “Molecular Cloning of the Human Hepatitis C Virus Genome Form Japanese Patients with Non-A Non-B Hepatitis”, Proc. Natl. Acad. Sci. USA, vol. 87, 1990, pp. 9254-9258, XP000168621.
Database Genban Online! Accession No. X78863, May 20, 1994 Van Doorn et al: “Sequence Analysis of Hepatitis C Virus Genotypes 1 to 5”, XP002017147 * abstract * and J. Gen. Virol., vol. 76, 1994, pp. 1871-1876.
Database Genban Online! Accession No. D26387, Feb. 4, 1994 Hotta et al: Subtype Analysis of Hepatitis C Virus in Indonesia XP002017146 * abstract * and J. Clin. Microbiol., vol. 32, 1994, pp. 3049-3051.
Biochem. Biophys. Res. Commun., vol. 170, No. 3, 1990, pp. 1021-1025, XPOO2017145 N. Enomoto et al: “There are Two Major Types of Hepatitis C Virus in Japan”.
Mori, S. et al, “A new type of hepatitis C in patients in Thailand”, Biochem. Biophys. Res. Commun. vol. 183, No. 1, 1992, pp. 334-342.
Chan, S.W. et al, “Analysis of a new hepatitis C type and its phylogenetic relationsip to existing variants”, J. Gen. Virol., vol. 73, 1992, pp. 1131-1141.
Chen et al, Virology 188, 102-113 (1992).
George et al, “Macromolecular Sequencing and Synthesis, Selected Methods and Applications”, pp. 127-149, 1988 Alan R. Liss, Inc.
Innis et al, “PCR Profocos. A Guide to Methods and Applications”. 1990 Academic Press, 113-12.
Choo et al. PNAS 1991 88, 2451-2455.
Genbank Accession No. M62321. Hepatitis C virus . . . [gi:329873] Hepatitis C virus polyprotein precursor (HCV-1) mRNA, complete cds; VRL Aug. 2, 1993 Choo,Q.-L., Richman,K., Han,J.H., Berger,K., Lee,C., Dong,C., Gallegos,C., Coit,D., Medina-Selby,A., Barr,P.J., Weiner,A., Bradley,D.W., Kuo,G. and Houghton,M. :Genetic organization and diversity of the hepatitis C virus, Proc. Natl. Acad. Sci. U.S.A. 88 (6), 2451-2455 (1991).
Maertens Geert
Stuyver Lieven
Innogenetics N.V.
Nixon & Vanderhye P.C.
Zeman Mary K.
LandOfFree
Sequences of hepatitis C virus genotypes and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequences of hepatitis C virus genotypes and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequences of hepatitis C virus genotypes and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3696949